Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2014-2026) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Bacterial Vaginosis Drug Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Bacterial Vaginosis Drug Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Bacterial Vaginosis Drug Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by Region) 5 Global Bacterial Vaginosis Drug Market-Segmentation by Type 5.1 Rx 5.2 OTC 6 Global Bacterial Vaginosis Drug Market-Segmentation by Application 6.1 Hospital 6.2 Pharmacy 6.3 Others 7 Global Bacterial Vaginosis Drug Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence – Company Profiles 8.1 Teva Pharmaceutical Industries 8.1.1 Teva Pharmaceutical Industries Profile 8.1.2 Teva Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2019E 8.1.3 Teva Pharmaceutical Industries Product/Solution Launches and Enhancements Analysis 8.1.4 Teva Pharmaceutical Industries Business Overview/Recent Development/Acquisitions 8.2 Sun Pharmaceutical Industries 8.2.1 Sun Pharmaceutical Industries Profile 8.2.2 Sun Pharmaceutical Industries Sales, Growth Rate and Global Market Share from 2014-2019E 8.2.3 Sun Pharmaceutical Industries Product/Solution Launches and Enhancements Analysis 8.2.4 Sun Pharmaceutical Industries Business Overview/Recent Development/Acquisitions 8.3 Novartis 8.3.1 Novartis Profile 8.3.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2019E 8.3.3 Novartis Product/Solution Launches and Enhancements Analysis 8.3.4 Novartis Business Overview/Recent Development/Acquisitions 8.4 Bayer 8.4.1 Bayer Profile 8.4.2 Bayer Sales, Growth Rate and Global Market Share from 2014-2019E 8.4.3 Bayer Product/Solution Launches and Enhancements Analysis 8.4.4 Bayer Business Overview/Recent Development/Acquisitions 8.5 Starpharma Holdings 8.5.1 Starpharma Holdings Profile 8.5.2 Starpharma Holdings Sales, Growth Rate and Global Market Share from 2014-2019E 8.5.3 Starpharma Holdings Product/Solution Launches and Enhancements Analysis 8.5.4 Starpharma Holdings Business Overview/Recent Development/Acquisitions 8.6 Symbiomix Therapeutics 8.6.1 Symbiomix Therapeutics Profile 8.6.2 Symbiomix Therapeutics Sales, Growth Rate and Global Market Share from 2014-2019E 8.6.3 Symbiomix Therapeutics Product/Solution Launches and Enhancements Analysis 8.6.4 Symbiomix Therapeutics Business Overview/Recent Development/Acquisitions 8.7 AstraZeneca 8.7.1 AstraZeneca Profile 8.7.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2014-2019E 8.7.3 AstraZeneca Product/Solution Launches and Enhancements Analysis 8.7.4 AstraZeneca Business Overview/Recent Development/Acquisitions 8.8 Starpharma 8.8.1 Starpharma Profile 8.8.2 Starpharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.8.3 Starpharma Product/Solution Launches and Enhancements Analysis 8.8.4 Starpharma Business Overview/Recent Development/Acquisitions 8.9 Sanofi 8.9.1 Sanofi Profile 8.9.2 Sanofi Sales, Growth Rate and Global Market Share from 2014-2019E 8.9.3 Sanofi Product/Solution Launches and Enhancements Analysis 8.9.4 Sanofi Business Overview/Recent Development/Acquisitions 8.10 Pfizer 8.10.1 Pfizer Profile 8.10.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2019E 8.10.3 Pfizer Product/Solution Launches and Enhancements Analysis 8.10.4 Pfizer Business Overview/Recent Development/Acquisitions 8.11 Cardinal Health 8.11.1 Cardinal Health Profile 8.11.2 Cardinal Health Sales, Growth Rate and Global Market Share from 2014-2019E 8.11.3 Cardinal Health Product/Solution Launches and Enhancements Analysis 8.11.4 Cardinal Health Business Overview/Recent Development/Acquisitions 8.12 Mylan 8.12.1 Mylan Profile 8.12.2 Mylan Sales, Growth Rate and Global Market Share from 2014-2019E 8.12.3 Mylan Product/Solution Launches and Enhancements Analysis 8.12.4 Mylan Business Overview/Recent Development/Acquisitions 8.13 LGM Pharma 8.13.1 LGM Pharma Profile 8.13.2 LGM Pharma Sales, Growth Rate and Global Market Share from 2014-2019E 8.13.3 LGM Pharma Product/Solution Launches and Enhancements Analysis 8.13.4 LGM Pharma Business Overview/Recent Development/Acquisitions 8.14 Allergan 8.14.1 Allergan Profile 8.14.2 Allergan Sales, Growth Rate and Global Market Share from 2014-2019E 8.14.3 Allergan Product/Solution Launches and Enhancements Analysis 8.14.4 Allergan Business Overview/Recent Development/Acquisitions 9 Global Bacterial Vaginosis Drug Market-Segmentation by Geography 10 North America 10.1 North America Bacterial Vaginosis Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 10.2 North America Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 10.3 North America Bacterial Vaginosis Drug Production Analysis from 2014-2019E 10.4 North America Bacterial Vaginosis Drug Consumption Analysis from 2014-2019E 10.5 North America Bacterial Vaginosis Drug Import and Export from 2014-2019E 10.6 North America Bacterial Vaginosis Drug Value, Production and Market Share by Type (2014-2019E) 10.7 North America Bacterial Vaginosis Drug Consumption, Value and Market Share by Application (2014-2019E) 10.8 North America Bacterial Vaginosis Drug by Country (United States, Canada) 10.8.1 North America Bacterial Vaginosis Drug Sales by Country (2014-2019E) 10.8.2 North America Bacterial Vaginosis Drug Consumption Value by Country (2014-2019E) 10.9 North America Bacterial Vaginosis Drug Market PEST Analysis 11 Europe 11.1 Europe Bacterial Vaginosis Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 11.2 Europe Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 11.3 Europe Bacterial Vaginosis Drug Production Analysis from 2014-2019E 11.4 Europe Bacterial Vaginosis Drug Consumption Analysis from 2014-2019E 11.5 Europe Bacterial Vaginosis Drug Import and Export from 2014-2019E 11.6 Europe Bacterial Vaginosis Drug Value, Production and Market Share by Type (2014-2019E) 11.7 Europe Bacterial Vaginosis Drug Consumption, Value and Market Share by Application (2014-2019E) 11.8 Europe Bacterial Vaginosis Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Bacterial Vaginosis Drug Sales by Country (2014-2019E) 11.8.2 Europe Bacterial Vaginosis Drug Consumption Value by Country (2014-2019E) 11.9 Europe Bacterial Vaginosis Drug Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Bacterial Vaginosis Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 12.2 Asia-Pacific Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 12.3 Asia-Pacific Bacterial Vaginosis Drug Production Analysis from 2014-2019E 12.4 Asia-Pacific Bacterial Vaginosis Drug Consumption Analysis from 2014-2019E 12.5 Asia-Pacific Bacterial Vaginosis Drug Import and Export from 2014-2019E 12.6 Asia-Pacific Bacterial Vaginosis Drug Value, Production and Market Share by Type (2014-2019E) 12.7 Asia-Pacific Bacterial Vaginosis Drug Consumption, Value and Market Share by Application (2014-2019E) 12.8 Asia-Pacific Bacterial Vaginosis Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Bacterial Vaginosis Drug Sales by Country (2014-2019E) 12.8.2 Asia-Pacific Bacterial Vaginosis Drug Consumption Value by Country (2014-2019E) 12.9 Asia-Pacific Bacterial Vaginosis Drug Market PEST Analysis 13 Latin America 13.1 Latin America Bacterial Vaginosis Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 13.2 Latin America Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 13.3 Latin America Bacterial Vaginosis Drug Production Analysis from 2014-2019E 13.4 Latin America Bacterial Vaginosis Drug Consumption Analysis from 2014-2019E 13.5 Latin America Bacterial Vaginosis Drug Import and Export from 2014-2019E 13.6 Latin America Bacterial Vaginosis Drug Value, Production and Market Share by Type (2014-2019E) 13.7 Latin America Bacterial Vaginosis Drug Consumption, Value and Market Share by Application (2014-2019E) 13.8 Latin America Bacterial Vaginosis Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Bacterial Vaginosis Drug Sales by Country (2014-2019E) 13.8.2 Latin America Bacterial Vaginosis Drug Consumption Value by Country (2014-2019E) 13.9 Latin America Bacterial Vaginosis Drug Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Bacterial Vaginosis Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2014-2019E 14.2 Middle East & Africa Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2014-2019E 14.3 Middle East & Africa Bacterial Vaginosis Drug Production Analysis from 2014-2019E 14.4 Middle East & Africa Bacterial Vaginosis Drug Consumption Analysis from 2014-2019E 14.5 Middle East & Africa Bacterial Vaginosis Drug Import and Export from 2014-2019E 14.6 Middle East & Africa Bacterial Vaginosis Drug Value, Production and Market Share by Type (2014-2019E) 14.7 Middle East & Africa Bacterial Vaginosis Drug Consumption, Value and Market Share by Application (2014-2019E) 14.8 Middle East & Africa Bacterial Vaginosis Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Bacterial Vaginosis Drug Sales by Country (2014-2019E) 14.8.2 Middle East & Africa Bacterial Vaginosis Drug Consumption Value by Country (2014-2019E) 14.9 Middle East & Africa Bacterial Vaginosis Drug Market PEST Analysis 15 Future Forecast of the Global Bacterial Vaginosis Drug Market from 2018-2026 15.1 Future Forecast of the Global Bacterial Vaginosis Drug Market from 2019-2026 Segment by Region 15.2 Global Bacterial Vaginosis Drug Production and Growth Rate Forecast by Type (2019-2026) 15.3 Global Bacterial Vaginosis Drug Consumption and Growth Rate Forecast by Application (2019-2026) 16 Appendix 16.1 Methodology 16.2 Research Data Source

List of Tables and Figures Global Bacterial Vaginosis Drug Market Value ($) and Growth Rate of Bacterial Vaginosis Drug from 2014-2026 Global Bacterial Vaginosis Drug Production and Growth Rate Segment by Product Type from 2014-2026F Global Bacterial Vaginosis Drug Consumption and Growth Rate Segment by Application from 2014-2019E Figure Bacterial Vaginosis Drug Picture Table Product Specifications of Bacterial Vaginosis Drug Table Driving Factors for this Market Table Industry News of Bacterial Vaginosis Drug Market Figure Value Chain Status of Bacterial Vaginosis Drug Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type) Table Distributors/Traders Table Downstream Major Customer Analysis (by Region, by Preference) Table Global Bacterial Vaginosis Drug Production and Growth Rate Segment by Product Type from 2014-2019E Table Global Bacterial Vaginosis Drug Value ($) and Growth Rate Segment by Product Type from 2014-2019E Figure Rx of Bacterial Vaginosis Drug Figure OTC of Bacterial Vaginosis Drug Table Global Bacterial Vaginosis Drug Consumption and Growth Rate Segment by Application from 2014-2019E Table Global Bacterial Vaginosis Drug Value ($) and Growth Rate Segment by Application from 2014-2019E Figure Hospital of Bacterial Vaginosis Drug Figure Pharmacy of Bacterial Vaginosis Drug Figure Others of Bacterial Vaginosis Drug Table Global Bacterial Vaginosis Drug Consumption and Growth Rate Segment by Marketing Channel from 2014-2019E Table Global Bacterial Vaginosis Drug Value ($) and Growth Rate Segment by Marketing Channel from 2014-2019E Figure Traditional Marketing Channel (Offline) of Bacterial Vaginosis Drug Figure Online Channel of Bacterial Vaginosis Drug Table Teva Pharmaceutical Industries Profile (Company Name, Plants Distribution, Sales Region) Figure Teva Pharmaceutical Industries Sales and Growth Rate from 2014-2019E Figure Teva Pharmaceutical Industries Revenue ($) and Global Market Share from 2014-2019E Table Teva Pharmaceutical Industries Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sun Pharmaceutical Industries Profile (Company Name, Plants Distribution, Sales Region) Figure Sun Pharmaceutical Industries Sales and Growth Rate from 2014-2019E Figure Sun Pharmaceutical Industries Revenue ($) and Global Market Share from 2014-2019E Table Sun Pharmaceutical Industries Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Novartis Profile (Company Name, Plants Distribution, Sales Region) Figure Novartis Sales and Growth Rate from 2014-2019E Figure Novartis Revenue ($) and Global Market Share from 2014-2019E Table Novartis Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Bayer Profile (Company Name, Plants Distribution, Sales Region) Figure Bayer Sales and Growth Rate from 2014-2019E Figure Bayer Revenue ($) and Global Market Share from 2014-2019E Table Bayer Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Starpharma Holdings Profile (Company Name, Plants Distribution, Sales Region) Figure Starpharma Holdings Sales and Growth Rate from 2014-2019E Figure Starpharma Holdings Revenue ($) and Global Market Share from 2014-2019E Table Starpharma Holdings Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Symbiomix Therapeutics Profile (Company Name, Plants Distribution, Sales Region) Figure Symbiomix Therapeutics Sales and Growth Rate from 2014-2019E Figure Symbiomix Therapeutics Revenue ($) and Global Market Share from 2014-2019E Table Symbiomix Therapeutics Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region) Figure AstraZeneca Sales and Growth Rate from 2014-2019E Figure AstraZeneca Revenue ($) and Global Market Share from 2014-2019E Table AstraZeneca Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Starpharma Profile (Company Name, Plants Distribution, Sales Region) Figure Starpharma Sales and Growth Rate from 2014-2019E Figure Starpharma Revenue ($) and Global Market Share from 2014-2019E Table Starpharma Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Sanofi Profile (Company Name, Plants Distribution, Sales Region) Figure Sanofi Sales and Growth Rate from 2014-2019E Figure Sanofi Revenue ($) and Global Market Share from 2014-2019E Table Sanofi Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Pfizer Profile (Company Name, Plants Distribution, Sales Region) Figure Pfizer Sales and Growth Rate from 2014-2019E Figure Pfizer Revenue ($) and Global Market Share from 2014-2019E Table Pfizer Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Cardinal Health Profile (Company Name, Plants Distribution, Sales Region) Figure Cardinal Health Sales and Growth Rate from 2014-2019E Figure Cardinal Health Revenue ($) and Global Market Share from 2014-2019E Table Cardinal Health Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Mylan Profile (Company Name, Plants Distribution, Sales Region) Figure Mylan Sales and Growth Rate from 2014-2019E Figure Mylan Revenue ($) and Global Market Share from 2014-2019E Table Mylan Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table LGM Pharma Profile (Company Name, Plants Distribution, Sales Region) Figure LGM Pharma Sales and Growth Rate from 2014-2019E Figure LGM Pharma Revenue ($) and Global Market Share from 2014-2019E Table LGM Pharma Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Allergan Profile (Company Name, Plants Distribution, Sales Region) Figure Allergan Sales and Growth Rate from 2014-2019E Figure Allergan Revenue ($) and Global Market Share from 2014-2019E Table Allergan Bacterial Vaginosis Drug Sales, Price, Revenue, Gross Margin (2014-2019E) Table Global Bacterial Vaginosis Drug Production Value ($) by Region from 2014-2019E Table Global Bacterial Vaginosis Drug Production Value Share by Region from 2014-2019E Table Global Bacterial Vaginosis Drug Production by Region from 2014-2019E Table Global Bacterial Vaginosis Drug Consumption Value ($) by Region from 2014-2019E Table Global Bacterial Vaginosis Drug Consumption by Region from 2014-2019E Table North America Bacterial Vaginosis Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table North America Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table North America Bacterial Vaginosis Drug Import and Export from 2014-2019E Table North America Bacterial Vaginosis Drug Value ($) by Type (2014-2019E) Table North America Bacterial Vaginosis Drug Production by Type (2014-2019E) Table North America Bacterial Vaginosis Drug Consumption by Application (2014-2019E) Table North America Bacterial Vaginosis Drug Consumption by Country (2014-2019E) Table North America Bacterial Vaginosis Drug Consumption Value ($) by Country (2014-2019E) Figure North America Bacterial Vaginosis Drug Market PEST Analysis Table Europe Bacterial Vaginosis Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Europe Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Europe Bacterial Vaginosis Drug Import and Export from 2014-2019E Table Europe Bacterial Vaginosis Drug Value ($) by Type (2014-2019E) Table Europe Bacterial Vaginosis Drug Production by Type (2014-2019E) Table Europe Bacterial Vaginosis Drug Consumption by Application (2014-2019E) Table Europe Bacterial Vaginosis Drug Consumption by Country (2014-2019E) Table Europe Bacterial Vaginosis Drug Consumption Value ($) by Country (2014-2019E) Figure Europe Bacterial Vaginosis Drug Market PEST Analysis Table Asia-Pacific Bacterial Vaginosis Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Asia-Pacific Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Asia-Pacific Bacterial Vaginosis Drug Import and Export from 2014-2019E Table Asia-Pacific Bacterial Vaginosis Drug Value ($) by Type (2014-2019E) Table Asia-Pacific Bacterial Vaginosis Drug Production by Type (2014-2019E) Table Asia-Pacific Bacterial Vaginosis Drug Consumption by Application (2014-2019E) Table Asia-Pacific Bacterial Vaginosis Drug Consumption by Country (2014-2019E) Table Asia-Pacific Bacterial Vaginosis Drug Consumption Value ($) by Country (2014-2019E) Figure Asia-Pacific Bacterial Vaginosis Drug Market PEST Analysis Table Latin America Bacterial Vaginosis Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Latin America Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Latin America Bacterial Vaginosis Drug Import and Export from 2014-2019E Table Latin America Bacterial Vaginosis Drug Value ($) by Type (2014-2019E) Table Latin America Bacterial Vaginosis Drug Production by Type (2014-2019E) Table Latin America Bacterial Vaginosis Drug Consumption by Application (2014-2019E) Table Latin America Bacterial Vaginosis Drug Consumption by Country (2014-2019E) Table Latin America Bacterial Vaginosis Drug Consumption Value ($) by Country (2014-2019E) Figure Latin America Bacterial Vaginosis Drug Market PEST Analysis Table Middle East & Africa Bacterial Vaginosis Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2014-2019E Table Middle East & Africa Bacterial Vaginosis Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2014-2019E Table Middle East & Africa Bacterial Vaginosis Drug Import and Export from 2014-2019E Table Middle East & Africa Bacterial Vaginosis Drug Value ($) by Type (2014-2019E) Table Middle East & Africa Bacterial Vaginosis Drug Production by Type (2014-2019E) Table Middle East & Africa Bacterial Vaginosis Drug Consumption by Application (2014-2019E) Table Middle East & Africa Bacterial Vaginosis Drug Consumption by Country (2014-2019E) Table Middle East & Africa Bacterial Vaginosis Drug Consumption Value ($) by Country (2014-2019E) Figure Middle East & Africa Bacterial Vaginosis Drug Market PEST Analysis Table Global Bacterial Vaginosis Drug Value ($) and Growth Rate Forecast by Region (2018-2026) Table Global Bacterial Vaginosis Drug Production and Growth Rate Forecast by Region (2019-2026) Table Global Bacterial Vaginosis Drug Consumption and Growth Rate Forecast by Region (2019-2026) Table Global Bacterial Vaginosis Drug Production and Growth Rate Forecast by Type (2019-2026) Table Global Bacterial Vaginosis Drug Consumption and Growth Rate Forecast by Application (2019-2026)